AARP Continues Nationwide Assault on High Drug Prices; 'Watchdog'Study Finds Soaring Rx Prices; Drug Affordability a Top StatePriority for AARP New York
U.S. Newswire, November, 2005
ALBANY, N.Y., Nov. 2 /U.S. Newswire/ -- A new prescription drug price report issued by AARP today found that the manufacturer prices for brand name prescription drugs continue to rise at an average rate that greatly outpaces general inflation. The Rx Watchdog Study found prices for nearly 200 of the most commonly used brand name drugs rose 6.1 percent over the course of a 12-month period, while the rate of inflation increased by just 3 percent.
"State, federal and family health care budgets are being stretched to the max, and sadly sometimes beyond," said Bill Novelli, AARP CEO. "It is simply unsustainable for American consumers to continue footing the bill for endless increases in drug prices."
AARP offices across the nation, including New York, are working with...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
